Publications by authors named "Andrew Slade"

Claim this Profile
A
A Prodrug Strategy to Reposition Atovaquone as a Long-Acting Injectable for Malaria Chemoprotection.
Anil K Gupta, Anders M Eliasen, Wil Andahazy, Fei Zhou, Kerstin Henson, Andrew Slade

bioRxiv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of a novel ATM inhibitor, KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer.
Michael A Batey, Yan Zhao, Suzanne Kyle, Caroline Richardson, Andrew Slade

Mol Cancer Ther· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3K.
Joanne M Munck, Michael A Batey, Yan Zhao, Helen Jenkins, Caroline J Richardson, Andrew Slade

Mol Cancer Ther· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of repair of radiation-induced DNA damage enhances gene expression from replication-defective adenoviral vectors.
Mohan Hingorani, Christine L White, Andrew Merron, Inge Peerlinck, Martin E Gore, Andrew Slade

Cancer Res· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanoma.
Jeremy P Braybrooke, Andrew Slade, Gael Deplanque, Richard Harrop, Srinivasan Madhusudan

Clin Cancer Res· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AN ANALYSIS OF THE INFLUENCE OF CLONE SIZE AND STOLON CONNECTIONS BETWEEN RAMETS ON THE GROWTH OF GLECHOMA HEDERACEA L.
Andrew J Slade, Michael J Hutchings

New Phytol· August 1987

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis